Stock Track | Akeso Shares Tumble 5.35% After Announcing $1.92 Billion Share Placement

Stock Track10-14

Shares of Akeso, a leading integrated drug discovery platform company, plummeted by 5.35% on October 14, 2024, following the announcement of a HK$1.92 billion share placement.

According to a filing with the Hong Kong stock exchange, Akeso plans to issue 31.7 million new shares, representing approximately 3.53% of the company's enlarged issued share capital, to at least six independent third parties at a price of HK$61.28 per share. The placement is being facilitated by Morgan Stanley Asia as the placing agent.

The significant share issuance appears to have raised concerns among investors about potential dilution of existing shareholders' stake in the company. Additionally, some market participants may have reservations about the planned use of proceeds, with 70% earmarked for clinical development of core products, 20% for commercialization of existing products, and 10% for general corporate purposes.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment